Buenos Aires, Argentina--For men with Peyronie's disease with or without erectile dysfunction, intralesional interferon alfa-2b (Intron-A) may offer a simple, safe, and effective treatment for improving penile curvature and the ability to have sexual intercourse. So say Cleveland Clinic researchers, who presented the results of a study on the drug in this population at the International Society for Sexual and Impotence Research world congress here.
Buenos Aires, Argentina--The serotonin transport inhibitor dapoxetine appears to be a well-tolerated and effective agent for the treatment of premature ejaculation, according to the results of a phase II study presented at the International Society for Sexual and Impotence Research world congress.
Mumbai, India--Since the introduction of laparoscopic surgery to urology in the early 1990s, academic and community urology programs alike have been striving to learn and advance the specialized skills required to perform laparoscopic urologic surgery. At the 22nd World Congress on Endourology, an extensive session was de-voted to reporting the recent advances made in the field of laparoscopic training.
Refinements in robotic technique help keep positive margin rates low, experts report
Mumbai, India--Technical advances in laparoscopic radical prostatectomy continue to improve the safety and efficacy of the procedure, according to a number of reports from the World Congress on Endourology here.
Chicago--In the wake of the surprising results of the Prostate Cancer Prevention Trial (PCPT), researchers continue to investigate possible therapies for prostate cancer prevention. Some focus on alternative therapies, with a major effort underway to determine the possible efficacy of selenium and vitamin E in the form of the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Chicago--A phase II clinical trial now enrolling patients aims to test the efficacy of an immunophilin ligand in assisting the regeneration of penile nerves following radical prostatectomy.
New York--Factors traditionally linked to risk assessment of prostate cancer—PSA, digital rectal examination, and age—are summed up in a new table that is designed for ease of use.
Buenos Aires, Argentina--The onset of action may be very rapid within 10 minutes in some men who take vardenafil (Levitra) to treat erectile dysfunction, according to the results of a multinational study.
Mumbai, India--Safeguarding sexual function following radical prostatectomy remains a great concern for patients undergoing the procedure. Preservation of the posterior-lateral prostatic neurovascular bundles at the time of surgery is critical for recovery of erectile function. The experience gained with the open radical retro-pubic prostatectomy has allowed urologists performing robotic prostatectomy to utilize an anatomic nerve-sparing approach to maximize the potential for recovery of sexual function.
It is evident that refined cognitive and surgical skills are necessary to remain proficient in urologic laparoscopy.
Buenos Aires, Argentina--In a multinational study aimed at pinpointing the attributes men consider desirable in treatments for erectile dysfunction, researchers have found that reliability of treatment ranks first, followed closely by tolerability.
Chicago--A panel of experts is expected to convene to reconsider the controversial findings of the Prostate Cancer Prevention Trial (PCPT), in particular, the indication that finasteride (Proscar) may prevent prostate cancer and yet lead to more severe grades of cancer in those men who develop it.
Some drug-resistant Escherichia coli strains causing urinary tract infections may have an animal origin, according to an article in Clinical Infectious Diseases (2005; 40:251-7).
The FDA granted tentative approval to generic versions of two popular urology drugs, one for BPH and the other for overactive bladder.
Investigators at the University of Michigan Comprehensive Cancer Center are using new MRI and CT techniques to target the prostate more precisely during radiation therapy and lower the risk of postoperative erectile dysfunction in men with prostate cancer, according to a report in the International Journal of Radiation Oncology Biology Physics (2005; 61:20-31).
Investigators at the University of Michigan Comprehensive Cancer Center are using new MRI and CT techniques to target the prostate more precisely during radiation therapy and lower the risk of postoperative erectile dysfunction in men with prostate cancer, according to a report in the International Journal of Radiation Oncology Biology Physics (2005; 61:20-31).
Ashutosh Tewari, MD, has been named director of robotic prostatectomy and prostate cancer outcomes in the Brady Urologic Health Center of the department of urology and the department of public health at New York-Presbyterian/Weill Cornell Medical Center.
A leading ophthalmology group has issued a physician advisory about a possible link between the alpha-blocker tamsulosin and a new small pupil syndrome known as intraoperative floppy iris syndrome.
Women with bladder control disorders believe they would benefit from more communication or interaction with their physician or nurse, according to a survey published in the December issue of Urologic Nursing.
The American Medical Association, American Medical Group Association, and Medical Group Management Association recently sent letters to their memberships urging physicians and physician groups to submit claims for the CIGNA Corp. managed care litigation settlement.
The risk of bone fractures increases for those prostate cancer patients on androgen-deprivation therapy by more than 40%, according an article in last week's New England Journal of Medicine (2005; 352:154-64).
Urology Times has added two leading urologic experts to its Editorial Council.
Prostate cancer patients receiving androgen deprivation therapy are frequently not screened nor treated for osteoporosis, according to an article in the online edition of Cancer (Dec. 13, 2004).
Urinary calcium influences the formation of calcium oxalate or calcium phosphate kidney stones, according to two studies by researchers from the University of Texas Southwestern Medical Center in Dallas.
The FDA has received a new drug application from ALZA Corp. for dapoxetine hydrochloride, a possible new treatment for premature ejaculation.
The FDA has approved extended-release darifenacin (Enablex, 7.5 mg and 15 mg) for the treatment of overactive bladder.
A combination of brachytherapy and external radiation plus androgen deprivation gives prostate cancer patients with high-risk disease a better chance of survival than patients treated with radiation alone, according to a study in the International Journal of Radiation Oncology*Biology*Physics (2005; 61:32-43).
MRI/MRSI is best suited for patients with newly diagnosed prostate cancer who are at high risk of extracapsular extent and who are considering various forms of local therapy.